Nancy E. Lane
Aging Center
Medicine and Rheumatology
University of California at Davis Medical Center
4800 2nd Avenue
USA
Name/email consistency: high
- Anabolic therapies. Lane, N.E., Silverman, S.L. Curr. Osteoporos. Rep (2010)
- Long-term effects of treatment with alendronate for patients with osteoporosis. Lane, N.E. Nat. Clin. Pract. Rheumatol (2007)
- Epidemiology, etiology, and diagnosis of osteoporosis. Lane, N.E. Am. J. Obstet. Gynecol. (2006)
- Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Lane, N.E. Nat. Clin. Pract. Rheumatol (2006)
- Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. Lane, N.E., Yao, W., Balooch, M., Nalla, R.K., Balooch, G., Habelitz, S., Kinney, J.H., Bonewald, L.F. J. Bone Miner. Res. (2006)
- Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?. Lane, N.E. Nature Clinical Practice. Rheumatology (2006)
- New perspectives on parathyroid hormone therapy. Lane, N., Morris, S. Curr. Opin. Rheumatol (2005)